Immune Response Molecular Biology Science 
Codon
JUNE 5, 2025
The core of the CRISPR immune response is a guide RNA (gRNA) that binds to a CRISPR-associated (Cas) protein. Traditional approaches to this problem involve the use of viral vectors , which run the risk of triggering immune responses in patients. Collectively, these repeat-protospacer regions are known as CRISPR arrays.
Broad Institute
JUNE 25, 2025
Isselbacher Professor of Medicine at Harvard Medical School, and director of the Center for Computational and Integrative Biology and core member in the Department of Molecular Biology at Massachusetts General Hospital. Lingjia Kong, a research scientist in the Xavier lab, is the first author on the study. and Harry B.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
DrugBank
MAY 15, 2024
This method was more about serendipity than science. But as molecular biology has advanced, so too has our approach to finding new drugs. Their size and mode of action allow for a broader interaction with target molecules, which can be advantageous in disrupting protein-protein interactions or modulating immune responses.
LifeSciVC
JULY 1, 2024
One thread that has run throughout it has been my passion for science as a lens for looking at the world. In particular, I love connecting science to daily life. Pfizer’s recent campaign around “ Science Will Win ” similarly appealed to the ethos of the power of science to help humanity. Remember life’s Central Dogma.
Drug Target Review
FEBRUARY 28, 2024
from 2003 to 2006, covering the biotechnology and life-science tools sectors. Earlier in his career, Mr Ho was responsible for FP&A and operational analysis at CuraGen Corporation and worked as an Associate on the Healthcare Investment Banking team at Cowen, Inc. gammadelta T cells link innate and adaptive immune responses.
Alta Sciences
JUNE 11, 2024
via Wikimedia Commons My fellow Altascientists and I recently attended the 2024 annual Boston Society Gene & Cell Therapy Conference , held at the wonderful Museum of Science in, of course, Boston, MA. Contact one of our experts today to discuss your gene therapy program.
Dark Matter Blog
JULY 16, 2021
The only subject in school that held my interest was biology. As soon as I learned about DNA and RNA, I wanted to be a molecular biologist. I wanted to use molecular biology to create drugs. 49 years ago, when I was 16 years old, I wanted to do exactly what I am doing now. The ultimate success is incredibly rewarding.
Expert insights. Personalized for you.
81 
Let's personalize your content